A wise consistency: engineering biology for conformity, reliability, predictability.

The next generation of synthetic biology applications will increasingly involve engineered organisms that exist in intimate contact with humans, animals and the rest of the environment. Examples include cellular and viral approaches for maintaining and improving health in humans and animals. The need for reliable and specific function in these environments may require more complex system designs than previously. In these cases the uncertainties in the behavior of biological building blocks, their hosts and their environments present a challenge for design of predictable and safe systems. Here, we review systematic methods for the effective characterization of these uncertainties that are lowering the barriers to predictive design of reliable complex biological systems.

[1]  Bryan Bartley,et al.  SYNTHETIC SYSTEMS AS MICROBIAL THREATS: PREDICTABILITY OF LOSS-OF-FUNCTION MUTATIONS IN ENGINEERED SYSTEMS , 2011 .

[2]  Christina D Smolke,et al.  A yeast‐based rapid prototype platform for gene control elements in mammalian cells , 2013, Biotechnology and bioengineering.

[3]  Gabriel C. Wu,et al.  Synthetic protein scaffolds provide modular control over metabolic flux , 2009, Nature Biotechnology.

[4]  A. Khoruts,et al.  Changes in the composition of the human fecal microbiome following bacteriotherapy for recurrent Clostridium difficile-associated diarrhea , 2010 .

[5]  Timothy S. Ham,et al.  A tightly regulated inducible expression system utilizing the fim inversion recombination switch. , 2006, Biotechnology and bioengineering.

[6]  D. Endy,et al.  Rewritable digital data storage in live cells via engineered control of recombination directionality , 2012, Proceedings of the National Academy of Sciences.

[7]  Adam P Arkin,et al.  RNA processing enables predictable programming of gene expression , 2012, Nature Biotechnology.

[8]  Julius B. Lucks,et al.  A modular strategy for engineering orthogonal chimeric RNA transcription regulators , 2013, Nucleic acids research.

[9]  Pratima Chowdary,et al.  Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. , 2011, The New England journal of medicine.

[10]  A. Melcher,et al.  Live viruses to treat cancer , 2013, Journal of the Royal Society of Medicine.

[11]  Thomas H. Segall-Shapiro,et al.  Modular control of multiple pathways using engineered orthogonal T7 polymerases , 2012, Nucleic acids research.

[12]  Ryan T Gill,et al.  Strategy for directing combinatorial genome engineering in Escherichia coli , 2012, Proceedings of the National Academy of Sciences.

[13]  W. Silen,et al.  Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. , 1958, Surgery.

[14]  F. Bushman,et al.  Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV. , 2013, Blood.

[15]  H. Salis.  The ribosome binding site calculator. , 2011, Methods in enzymology.

[16]  Christopher A. Voigt,et al.  Ribozyme-based insulator parts buffer synthetic circuits from genetic context , 2012, Nature Biotechnology.

[17]  A. Arkin,et al.  Contextualizing context for synthetic biology – identifying causes of failure of synthetic biological systems , 2012, Biotechnology journal.

[18]  Igor M. Rouzine,et al.  Design Requirements for Interfering Particles To Maintain Coadaptive Stability with HIV-1 , 2012, Journal of Virology.

[19]  Miles Miller,et al.  Modular Design of Artificial Tissue Homeostasis: Robust Control through Synthetic Cellular Heterogeneity , 2012, PLoS Comput. Biol..

[20]  Adam P. Arkin,et al.  From Biological Parts to Circuit Design , 2013 .

[21]  Christopher A. Voigt,et al.  Genetic programs constructed from layered logic gates in single cells , 2012, Nature.

[22]  H. Fang,et al.  Clinical trials with oncolytic adenovirus in China. , 2007, Current cancer drug targets.

[23]  Vivek K. Mutalik,et al.  Measurement and modeling of intrinsic transcription terminators , 2013, Nucleic acids research.

[24]  Stefano Cardinale,et al.  Effects of genetic variation on the E. coli host-circuit interface. , 2013, Cell reports.

[25]  Daniel E. Williams,et al.  Ameliorating risk: Culturable and metagenomic monitoring of the 14 year decline of a genetically engineered microorganism at a bioremediation field site , 2012 .

[26]  F. Schmidt,et al.  Optimization and scale up of industrial fermentation processes , 2005, Applied Microbiology and Biotechnology.

[27]  Bernd Hauck,et al.  Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. , 2013, The New England journal of medicine.

[28]  Ahmad S. Khalil,et al.  A Synthetic Biology Framework for Programming Eukaryotic Transcription Functions , 2012, Cell.

[29]  Kathleen A. Marshall,et al.  Safety and efficacy of gene transfer for Leber's congenital amaurosis. , 2008, The New England journal of medicine.

[30]  Tom Ellis,et al.  Rational Diversification of a Promoter Providing Fine-Tuned Expression and Orthogonal Regulation for Synthetic Biology , 2012, PloS one.

[31]  J Christopher Anderson,et al.  Modular design of a synthetic payload delivery device. , 2013, ACS synthetic biology.

[32]  Alvaro R. Lara,et al.  Living with heterogeneities in bioreactors , 2006, Molecular biotechnology.

[33]  Christopher A. Voigt,et al.  Environmental signal integration by a modular AND gate , 2007, Molecular systems biology.

[34]  Adam P Arkin,et al.  An adaptor from translational to transcriptional control enables predictable assembly of complex regulation , 2012, Nature Methods.

[35]  Drew Endy,et al.  Amplifying Genetic Logic Gates , 2013, Science.

[36]  A. Arkin,et al.  Sequestration-based bistability enables tuning of the switching boundaries and design of a latch , 2012, Molecular systems biology.

[37]  Vivek K. Mutalik,et al.  Composability of regulatory sequences controlling transcription and translation in Escherichia coli , 2013, Proceedings of the National Academy of Sciences.

[38]  Christopher A. Voigt,et al.  Environmentally controlled invasion of cancer cells by engineered bacteria. , 2006, Journal of molecular biology.

[39]  Drew Endy,et al.  Quantitative estimation of activity and quality for collections of functional genetic elements , 2013, Nature Methods.

[40]  Gabriel C. Wu,et al.  Successes and failures in modular genetic engineering. , 2012, Current Opinion in Chemical Biology.

[41]  Weston R. Whitaker,et al.  Toward scalable parts families for predictable design of biological circuits. , 2008, Current opinion in microbiology.

[42]  Adam P. Arkin,et al.  Theoretical Design of a Gene Therapy To Prevent AIDS but Not Human Immunodeficiency Virus Type 1 Infection , 2003, Journal of Virology.

[43]  Julius B. Lucks,et al.  Engineering naturally occurring trans-acting non-coding RNAs to sense molecular signals , 2012, Nucleic acids research.

[44]  Drew Endy,et al.  Precise and reliable gene expression via standard transcription and translation initiation elements , 2013, Nature Methods.

[45]  Matthew R Bennett,et al.  Library of synthetic transcriptional AND gates built with split T7 RNA polymerase mutants , 2013, Proceedings of the National Academy of Sciences.

[46]  Eric Klavins,et al.  Fine-tuning gene networks using simple sequence repeats , 2012, Proceedings of the National Academy of Sciences.

[47]  H. Sauro,et al.  Rationally designed bidirectional promoter improves the evolutionary stability of synthetic genetic circuits , 2012, Nucleic acids research.

[48]  Luke A. Gilbert,et al.  Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression , 2013, Cell.

[49]  Adam P Arkin,et al.  Supplementary information for Rationally designed families of orthogonal RNA regulators of translation , 2012 .

[50]  Christopher A. Voigt,et al.  Characterization of 582 natural and synthetic terminators and quantification of their design constraints , 2013, Nature Methods.

[51]  A. Dunker,et al.  Sweeping away protein aggregation with entropic bristles: intrinsically disordered protein fusions enhance soluble expression. , 2012, Biochemistry.

[52]  E. Zoetendal,et al.  Duodenal infusion of donor feces for recurrent Clostridium difficile. , 2013, The New England journal of medicine.

[53]  S. Lee,et al.  Systems metabolic engineering, industrial biotechnology and microbial cell factories , 2012, Microbial Cell Factories.

[54]  A. Bagg,et al.  Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. , 2011, The New England journal of medicine.

[55]  Terry Hazen,et al.  Molecular Systems Biology 9; Article number 674; doi:10.1038/msb.2013.30 Citation: Molecular Systems Biology 9:674 , 2022 .

[56]  Nick Tyler,et al.  Effect of gene therapy on visual function in Leber's congenital amaurosis. , 2008, The New England journal of medicine.

[57]  John R. Mascola,et al.  Gene transfer in humans using a conditionally replicating lentiviral vector , 2006, Proceedings of the National Academy of Sciences.

[58]  Christopher A. Voigt,et al.  Genetic circuit performance under conditions relevant for industrial bioreactors. , 2012, ACS synthetic biology.

[59]  Adam P Arkin,et al.  Versatile RNA-sensing transcriptional regulators for engineering genetic networks , 2011, Proceedings of the National Academy of Sciences.

[60]  Alan Villalobos,et al.  Engineering genes for predictable protein expression. , 2012, Protein expression and purification.

[61]  Kenneth Evan Thompson,et al.  SYNZIP Protein Interaction Toolbox: in Vitro and in Vivo Specifications of Heterospecific Coiled-Coil Interaction Domains , 2012, ACS synthetic biology.

[62]  Nanette R Boyle,et al.  Engineering improved ethanol production in Escherichia coli with a genome-wide approach. , 2013, Metabolic engineering.

[63]  Christopher A. Voigt,et al.  Robust multicellular computing using genetically encoded NOR gates and chemical ‘wires’ , 2011, Nature.